01 7Adcock Ingram
02 2Aristo Pharma GmbH
03 1Ascent Innovative Medicines
04 1CRINOS SpA
05 4Chartwell Pharmaceuticals llc
06 1Chongqing Huapont Pharmaceutical
07 2Cosette Pharma
08 2Dermapharm Holding
09 1Farmatek
10 1Fougera Pharmaceuticals Inc.
11 1GLENMARK SPECLT
12 2Glenmark Pharmaceuticals
13 1Hikma Pharmaceuticals
14 1INTENDIS SpA
15 2Kolmar Korea Co., Ltd.
16 44Leo Pharma
17 1MC2 Therapeutics
18 1Mayne Pharma
19 2Mepha Pharma
20 6ORGANON CANADA INC.
21 1PRODOTTI FORMENTI Srl
22 2Padagis
23 10Sandoz B2B
24 4Taro Pharmaceutical Industries
25 9Teva Pharmaceutical Industries
26 4mibe GmbH Pharmaceuticals
01 1AEROSOL, FOAM
02 3AEROSOL, FOAM;TOPICAL
03 1CRE
04 8CREAM
05 4CREAM;TOPICAL
06 1CUTANEOUS SOLUTION
07 4Calcipotriolo 0.005% 30G Ointment Dermatological Use
08 3Calcipotriolo 0.005% 30Ml Solution Dermatological Use
09 2Calcipotriolo+Betamethasone 30G 50Mcg/G+0,5Mg/G Dermatological Use Gel
10 1Celiprololo 200Mg 28 Combined Oral Use
11 3Cream
12 3Foam
13 3GEL
14 16Gel
15 4LOTION
16 4OIN
17 12OINTMENT
18 5OINTMENT;TOPICAL
19 11Ointment
20 1SLN
21 6SOLUTION;TOPICAL
22 5SUSPENSION;TOPICAL
23 4Salbe
24 6Salve
25 2Blank
01 5DISCN
02 3Generic
03 4Originator
04 23Prescription
05 17RX
06 61Blank
01 2ARIBEC*
02 2CALBETA*
03 8CALCIPOTRIENE
04 5CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
05 1CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
06 1CALCIPOTRIOL SANDZ
07 3Calcipotriol Sandoz
08 2Calcipotriol-Betamethasone-Mepha
09 1Calcipotriolo
10 1Calmio Gel
11 1Calmio Ointmentment
12 1Cordiax
13 2DAIVONEX
14 1DIPROLENE
15 1DIPROSALIC
16 3DIPROSONE
17 1DOVOBET GEL
18 2DOVOBET OINTMENT
19 1DOVOBET*
20 4DOVONEX
21 13Daivobet
22 3Daivonex
23 4Dovobet
24 4Dovonex
25 1Dovonex Cream
26 1Dovonex Scalp Solution
27 2ENSTILAR
28 3Enstilar
29 1LOTRIDERM
30 2PSOTRIOL*
31 3Psorcutan
32 2Psotriol
33 1RATIO-TOPISALIC
34 1SORILUX
35 3TACLONEX
36 1TARO-CALCIPOTRIOL / BETAMETHASONE GEL
37 1TARO-CLOTRIMAZOLE/BETAMETHASONE DIPROPIONATE
38 1TARO-SONE
39 2TEVA-BETAMETHASONE/ CALCIPOTRIOL
40 3TEVA-TOPILENE
41 3TEVA-TOPISONE
42 1Token
43 1WYNZORA
44 1XAMIOL*
45 3Xamiol
46 1Xamiol Gel
47 2ZORIPOT*
48 3Zoriaxiol
49 3Blank
01 23Canada
02 1China
03 1India
04 25Italy
05 14Norway
06 7South Africa
07 2South Korea
08 5Sweden
09 11Switzerland
10 1Turkey
11 23USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALCIPOTRIENE
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 2009-11-20
Application Number : 77029
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALCIPOTRIENE
Dosage Form : CREAM;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 2012-05-30
Application Number : 200935
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Brand Name : CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Dosage Form : OINTMENT;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date : 2013-01-14
Application Number : 201615
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CALCIPOTRIENE
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 2017-12-26
Application Number : 207163
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CALCIPOTRIENE
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 2011-03-24
Application Number : 78468
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Brand Name : CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Dosage Form : SUSPENSION;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date : 2020-05-11
Application Number : 210765
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CALCIPOTRIENE
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 2008-05-06
Application Number : 78305
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CALCIPOTRIENE
Dosage Form : OINTMENT;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 2010-03-24
Application Number : 90633
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Brand Name : CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Dosage Form : AEROSOL, FOAM;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date : 2023-03-21
Application Number : 214688
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CALCIPOTRIENE
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 2009-11-19
Application Number : 77579
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOVONEX
Dosage Form : OINTMENT;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 1993-12-29
Application Number : 20273
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : DOVONEX
Dosage Form : CREAM;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 1996-07-22
Application Number : 20554
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : DOVONEX
Dosage Form : SOLUTION;TOPICAL
Dosage Strength : 0.005% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Packaging :
Approval Date : 1997-03-03
Application Number : 20611
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Brand Name : TACLONEX
Dosage Form : OINTMENT;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date : 2006-01-09
Application Number : 21852
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Brand Name : TACLONEX
Dosage Form : SUSPENSION;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date : 2008-05-09
Application Number : 22185
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE HYDRATE
Brand Name : TACLONEX
Dosage Form : SUSPENSION;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date :
Application Number : 22185
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Brand Name : ENSTILAR
Dosage Form : AEROSOL, FOAM;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date : 2015-10-16
Application Number : 207589
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Dovonex
Dosage Form : CREAM
Dosage Strength : 50 G / G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Dovonex
Dosage Form : OINTMENT
Dosage Strength : 50 G / G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Italy
Brand Name : Daivonex
Dosage Form : Calcipotriolo 0.005% 30G Ointment Dermatological Use
Dosage Strength : ung derm 30 g 0.005%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : Psorcutan
Dosage Form : Calcipotriolo 0.005% 30G Ointment Dermatological Use
Dosage Strength : cream hydrophobic derm 30 g 0.005%
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : SORILUX
Dosage Form : AEROSOL, FOAM;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 2010-10-06
Application Number : 22563
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Brand Name : WYNZORA
Dosage Form : CREAM;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date : 2020-07-20
Application Number : 213422
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Brand Name : CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Dosage Form : OINTMENT;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date : 2014-12-12
Application Number : 200174
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Brand Name : CALCIPOTRIENE AND BETHAMETHASONE DIPROPIONATE
Dosage Form : SUSPENSION;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date : 2020-09-11
Application Number : 212367
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : Sweden
Brand Name : Zoriaxiol
Dosage Form : CUTANEOUS SOLUTION
Dosage Strength : 50 MICROGRAM / ML
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Zoriaxiol
Dosage Form : CREAM
Dosage Strength : 0.05 MG / G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info :
Registration Country : Sweden
Brand Name : Zoriaxiol
Dosage Form : OINTMENT
Dosage Strength : 0.05 MG / G
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Sweden
Regulatory Info : RX
Registration Country : USA
BETAMETHASONE DIPROPIONATE; CALCIPOTRIENE
Brand Name : CALCIPOTRIENE AND BETAMETHASONE DIPROPIONATE
Dosage Form : SUSPENSION;TOPICAL
Dosage Strength : 0.064%;0.005%
Packaging :
Approval Date : 2020-09-02
Application Number : 213269
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : CALCIPOTRIENE
Dosage Form : CREAM;TOPICAL
Dosage Strength : 0.005%
Packaging :
Approval Date : 2015-06-09
Application Number : 205772
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?
